Calmare Therapeutics Incorporated

1375 Kings Highway East

Fairfield, CT 06824 33321

 

November 13, 2014

 

 

VIA EDGAR

Division of Corporation Finance

Securities and Exchange Commission

100 F Street N.E.

Washington, D.C. 20549

 

Re:Calmare Therapeutics Incorporated

Registration Statement on Form S-1

Filed July 22, 2013

File No. 333- 190069

 

Ladies and Gentlemen:

 

Pursuant to Rule 477 under the Securities Act of 1933 (the “Act”), Calmare Therapeutics Incorporated (the “Company”) requests the withdrawal of the Company’s Registration Statement on Form S-1 originally filed on July 22, 2013, File No. 333-190069 (the “S-1 Registration Statement”). The Company has elected to withdraw the S-1 Registration Statement because it does not want to pursue an offering at this time. No sales of the Company’s common stock have been or will be made pursuant to the S-1 Registration Statement.

 

The Company requests that in accordance with Rule 457(p) under the Act, all fees paid to the Commission in connection with the filing of the above-captioned registration statement be credited for future use. If you have any questions regarding this request for withdrawal, please contact our legal counsel, Gregg E. Jaclin at (609) 275-0400.

 

Sincerely,

 

Calmare Therapeutics Incorporated

  

By:  /s/ Conrad Mir  
Name: Conrad Mir  
Title: Chief Executive Officer  

 

 

Calmare Therapeutics (CE) (USOTC:CTTC)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Calmare Therapeutics (CE) Charts.
Calmare Therapeutics (CE) (USOTC:CTTC)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Calmare Therapeutics (CE) Charts.